Browse All

Current Filters

CLEAR FILTER x

TITLE

Collateral Damage: Immune Checkpoint Inhibitor-induced Myeloneuropathy in a Patient with Merkel Cell Carcinoma

Author:Singh, Simranpreet   Paliwal, Arjun   Shivangi, FNU   Viereck, Matthew   

Session Name:P6: Autoimmune Neurology: Immune Checkpoint Inhibitor and CAR-T 1  

Topic:Autoimmune Neurology  

Program Number:P6.006  

Author Institution:Tower Health Reading Hospital, PA, Reading, PA  Tower Health Reading Hospital, PA, West Reading, PA  

Unmasking The Silent NIF-IFA Autoimmunity: A Rare Case Report of Pembrolizumab-linked Encephalitis

Author:Gupta, MBBS, Manasvi   Mehta, MBBS, Vishal   Mauk, MD, Jarrett   Sudhakar, MD, Padmaja   Garcia Stangherlin, MD, Catherine R.   Ajjeya Gowder, MD, Mangayarkarasi Thandampallayam   

Session Name:P6: Autoimmune Neurology: Immune Checkpoint Inhibitor and CAR-T 1  

Topic:Autoimmune Neurology  

Program Number:P6.007  

Author Institution:All India Institute of Medical Sciences, New Delhi, New Delhi, India  University of Kentucky College of Medicine, Lexington, KY  

A Real-world Comparative Study on the Efficacy and Safety of Inebilizumab versus Rituximab in the Treatment of Neuromyelitis Optica Spectrum Disorder

Author:Zhu, Wenping   Shen, Ang   Liu, Hongbo   

Session Name:P6: Autoimmune Neurology: NMOSD/MOGAD 5  

Topic:Autoimmune Neurology  

Program Number:P6.007  

Author Institution:The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China, People's Republic of  The First Affiliated Hospital of Zhengzhou University, China, People's Republic of  

Clinical and Paraclinical Features Distinguishing Paraneoplastic from Immune Checkpoint Inhibitor-induced Encephalitis

Author:Zhao, Sophia   Benderoth, Jordan   Habis, Ralph   El Zibaoui, Roba   Venkatesan, Arun   Probasco, John   

Session Name:P6: Autoimmune Neurology: Immune Checkpoint Inhibitor and CAR-T 1  

Topic:Autoimmune Neurology  

Program Number:P6.008  

Author Institution:The Johns Hopkins University School of Medicine, Baltimore, MD  Johns Hopkins School of Medicine, Baltimore, MD  The Johns Hopkins University School of Medicine, MD  Johns Hopkins Hospital, Baltimore, MD  The Johns Hopkins Hospital, Baltimore, MD  

Steroid Use after the Inaugural Attack is a Meaningful Clinical Prognosticator in Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

Author:Tanasescu, Radu   Human, Matthew   Papathanasiou, Athanasios   Tench, Christopher   Gilmartin, Christopher   Siriratnam, Pakeeran   Rocchi, Chiara   Hargovan-Lalloo, Milan   Gran, Bruno   The, Ei Zune   Varley, James   Huda, Saif   

Session Name:P6: Autoimmune Neurology: NMOSD/MOGAD 5  

Topic:Autoimmune Neurology  

Program Number:P6.008  

Author Institution:Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom  University of Nottingham, Nottingham, United Kingdom  Academic Clinical Neurology, University of Nottingham, United Kingdom  The NMOSD Specialist Service, The Walton Centre, Liverpool, United Kingdom  Department of Neurology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom  Department of Neurology, Leicester Royal Infirmary, Leicester, United Kingdom